[UnicoCell Biotech] Announcement of Important Resolutions from the 2026 Annual General Meeting
UnicoCell Biotech held its annual general meeting on May 20, 2026, approving the 2025 fiscal year financial results, electing the sixth board of directors, and passing resolutions for capital policies including private placement.
📋 Article Processing Timeline
- 📰 Published: May 20, 2026 at 09:00
- 🔍 Collected: May 21, 2026 at 08:00 (23h 0m after Published)
- 🤖 AI Analyzed: May 21, 2026 at 08:37 (37 min after Collected)
1. Date of Annual General Meeting: 2026/05/20
2. Important Resolution 1, Earnings distribution or loss appropriation: Approved the proposal for appropriation of losses for the 2025 fiscal year.
3. Important Resolution 2, Articles of Incorporation amendment: Approved the amendment to the Articles of Incorporation.
4. Important Resolution 3, Business report and financial statements: Approved the business report and financial statements for the 2025 fiscal year.
5. Important Resolution 4, Election of directors and supervisors: Elected 9 members for the 6th board of directors (including 3 independent directors).
6. Important Resolution 5, Other matters:
(1) Approved the lifting of non-compete restrictions for new directors.
(2) Approved the amendment to the 'Procedures for Acquisition or Disposal of Assets'.
(3) Approved the proposal for the 1st private placement of common shares in 2026.
(4) Approved the issuance of restricted stock units for employees in 2026.
7. Other matters to be specified: None.
2. Important Resolution 1, Earnings distribution or loss appropriation: Approved the proposal for appropriation of losses for the 2025 fiscal year.
3. Important Resolution 2, Articles of Incorporation amendment: Approved the amendment to the Articles of Incorporation.
4. Important Resolution 3, Business report and financial statements: Approved the business report and financial statements for the 2025 fiscal year.
5. Important Resolution 4, Election of directors and supervisors: Elected 9 members for the 6th board of directors (including 3 independent directors).
6. Important Resolution 5, Other matters:
(1) Approved the lifting of non-compete restrictions for new directors.
(2) Approved the amendment to the 'Procedures for Acquisition or Disposal of Assets'.
(3) Approved the proposal for the 1st private placement of common shares in 2026.
(4) Approved the issuance of restricted stock units for employees in 2026.
7. Other matters to be specified: None.
FAQ
What major capital raising plans were approved at UnicoCell's shareholder meeting?
The meeting approved the private placement of common shares for 2026 and the issuance of restricted stock units for employees.
What is the structure of the newly elected board?
The sixth board of directors consists of nine members, including three independent directors.
Did the company amend its asset handling procedures?
Yes, the meeting passed the amendment to the 'Procedures for Acquisition or Disposal of Assets'.